These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 19412496)

  • 1. Psychopharmacology of topiramate: from epilepsy to bipolar disorder.
    Mula M; Cavanna AE; Monaco F
    Neuropsychiatr Dis Treat; 2006 Dec; 2(4):475-88. PubMed ID: 19412496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.
    Wilby J; Kainth A; Hawkins N; Epstein D; McIntosh H; McDaid C; Mason A; Golder S; O'Meara S; Sculpher M; Drummond M; Forbes C
    Health Technol Assess; 2005 Apr; 9(15):1-157, iii-iv. PubMed ID: 15842952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of topiramate, a new anti-epileptic as a mood stabilizer.
    Marcotte D
    J Affect Disord; 1998 Sep; 50(2-3):245-51. PubMed ID: 9858083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topiramate: its pharmacological properties and therapeutic efficacy in epilepsy.
    Latini G; Verrotti A; Manco R; Scardapane A; Del Vecchio A; Chiarelli F
    Mini Rev Med Chem; 2008 Jan; 8(1):10-23. PubMed ID: 18220981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topiramate in refractory epilepsy: a prospective observational study.
    Stephen LJ; Sills GJ; Brodie MJ
    Epilepsia; 2000 Aug; 41(8):977-80. PubMed ID: 10961624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topiramate.
    Glauser TA
    Semin Pediatr Neurol; 1997 Mar; 4(1):34-42. PubMed ID: 9097365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topiramate in the treatment of partial and generalized epilepsy.
    Faught E
    Neuropsychiatr Dis Treat; 2007 Dec; 3(6):811-21. PubMed ID: 19300616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characteristics and indications of topiramate].
    Nieto-Barrera M
    Rev Neurol; 2002 Sep; 35 Suppl 1():S88-95. PubMed ID: 12373660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topiramate monotherapy in the treatment of newly or recently diagnosed epilepsy.
    Ben-Menachem E; Sander JW; Stefan H; Schwalen S; Schäuble B
    Clin Ther; 2008 Jul; 30(7):1180-95. PubMed ID: 18691980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term experience with topiramate as adjunctive therapy and as monotherapy in patients with partial onset seizures: retrospective survey of open-label treatment.
    Rosenfeld WE; Sachdeo RC; Faught RE; Privitera M
    Epilepsia; 1997; 38 Suppl 1():S34-6. PubMed ID: 9092957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pooled analysis of adjunctive topiramate in refractory partial epilepsy.
    Peeters K; Adriaenssen I; Wapenaar R; Neto W; Pledger G
    Acta Neurol Scand; 2003 Jul; 108(1):9-15. PubMed ID: 12807387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary observations on topiramate in pediatric epilepsies.
    Glauser TA
    Epilepsia; 1997; 38 Suppl 1():S37-41. PubMed ID: 9092958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, open-label, multicenter comparative trial of levetiracetam and topiramate as adjunctive treatment for patients with focal epilepsy in Korea.
    Lee SK; Lee SA; Kim DW; Loesch C; Pelgrims B; Osakabe T; Lee B;
    Epilepsy Behav; 2019 Aug; 97():67-74. PubMed ID: 31195326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy of topiramate as add-on therapy in refractory partial epilepsy: the European experience.
    Ben-Menachem E
    Epilepsia; 1997; 38 Suppl 1():S28-30. PubMed ID: 9092955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review.
    Nolan SJ; Sudell M; Tudur Smith C; Marson AG
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD012065. PubMed ID: 27922722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topiramate as add-on treatment for patients with bipolar mania.
    Chengappa KN; Rathore D; Levine J; Atzert R; Solai L; Parepally H; Levin H; Moffa N; Delaney J; Brar JS
    Bipolar Disord; 1999 Sep; 1(1):42-53. PubMed ID: 11256656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topiramate: efficacy and tolerability in children according to epilepsy syndromes.
    Mikaeloff Y; de Saint-Martin A; Mancini J; Peudenier S; Pedespan JM; Vallée L; Motte J; Bourgeois M; Arzimanoglou A; Dulac O; Chiron C
    Epilepsy Res; 2003 Mar; 53(3):225-32. PubMed ID: 12694931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of topiramate as adjunctive therapy in refractory partial seizures: United States trial experience.
    Faught E
    Epilepsia; 1997; 38 Suppl 1():S24-7. PubMed ID: 9092954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topiramate in the long-term management of refractory epilepsy. Topiramate YOL Study Group.
    Abou-Khalil B
    Epilepsia; 2000; 41(S1):72-6. PubMed ID: 10768305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.